Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones | MicrobiomeTrials
Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2020-08-04Est. Completion: 2027-06-30
Enrollment target: 70 participants
Locations
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
City of Hope Comprehensive Cancer Center, Duarte, California, United States
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States
University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables, Florida, United States
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach, Florida, United States
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida, United States
UM Sylvester Comprehensive Cancer Center at Kendall, Miami, Florida, United States
UM Sylvester Comprehensive Cancer Center at Plantation, Plantation, Florida, United States
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States
University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States
University of Kansas Clinical Research Center, Fairway, Kansas, United States
Other microbiome trials you might be interested in
Locally Advanced Unresectable Breast CarcinomaMetastatic Breast CarcinomaRecurrent Breast CarcinomaStage IIIB Breast Cancer AJCC v7Stage IIIC Breast Cancer AJCC v7Stage IV Breast Cancer AJCC v6 and v7
This phase I trial studies the side effects and best dose of cyclophosphamide and veliparib when given together in treat…
New York, United StatesEst. completion Nov 25, 2016